Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Cigna Stock (CI) Opinions on Recent Analyst Downgrades Following Q2 Earnings

None

Downgrades Spark Caution: Analysts at Jefferies shifted Cigna to hold from buy with a reduced target of 307. Raymond James followed suit lowering its rating and price objective amid limited near-term catalysts. The moves came shortly after the company's quarterly update.

Earnings Mixed Signals: Cigna posted solid revenue growth yet faced pressure on core pharmacy benefits margins. Specialty care expansion offered some offset while the firm announced its exit from certain Obamacare plans. Traders noted the stock's premarket dip in response.

Target Adjustments Vary: Goldman Sachs countered the trend by raising its objective while keeping a buy stance. Overall chatter reflected tempered views on near-term momentum despite some positive adjustments elsewhere.

Note: This discussion summary was generated from an AI condensation of post data.

Cigna Insider Trading Activity

CI Insider Trades

Cigna insiders have traded $CI stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:

  • DAVID CORDANI (Chairman & CEO) has made 0 purchases and 13 sales selling 201,878 shares for an estimated $59,114,186.
  • NICOLE S JONES (See Remarks) sold 2,307 shares for an estimated $666,515
  • EVERETT NEVILLE (See Remarks) sold 1,719 shares for an estimated $496,636
  • JAMIE G KATES (Chief Accounting Officer) sold 899 shares for an estimated $268,452

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS
Receive CI Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

Cigna Revenue

CI Quarterly Revenue

Cigna had revenues of $71.7B in Q2 2026. This is an increase of 6.68% from the same period in the prior year.

You can track CI financials on Quiver Quantitative's CI stock page.

You can access data on CI stock through the Quiver Quantitative API.

Cigna Congressional Stock Trading

Members of Congress have traded $CI stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CI stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Cigna Hedge Fund Activity

We have seen 756 institutional investors add shares of Cigna stock to their portfolio, and 659 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Cigna Government Contracts

We have seen $3,613,672 of award payments to $CI over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Cigna Price Targets

Multiple analysts have issued price targets for $CI recently. We have seen 14 analysts offer price targets for $CI in the last 6 months, with a median target of $339.0.

Here are some recent targets:

  • Lance Wilkes from Bernstein set a target price of $381.0 on 07/09/2026
  • Ann Hynes from Mizuho set a target price of $340.0 on 06/08/2026
  • Andrew Mok from Barclays set a target price of $304.0 on 05/26/2026
  • A.J. Rice from UBS set a target price of $400.0 on 05/22/2026
  • Erin Wright from Morgan Stanley set a target price of $361.0 on 05/20/2026
  • George Hill from Deutsche Bank set a target price of $302.0 on 05/20/2026
  • Jason Cassorla from Guggenheim set a target price of $338.0 on 05/04/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles